Table 1.
Demographic and clinical characteristics of the study patients.
| Total | Group A | Group B | Group C | Group D | p | |
|---|---|---|---|---|---|---|
| Age (year) | 60 (52-69) | 59.43 ± 14.19 | 60.12 ± 15.61 | 62.86 ± 13.31 | 59.76 ± 11.7 | 0.487 |
| Male (%) | 55.8 | 52.7 | 56 | 53.1 | 60.5 | 0.614 |
| Neutrophil (109/l) | 4.05 (3.18-5.01) | 3.72 ± 1.3 | 3.02 (2.54-3.66) | 4.69 (3.94-6) | 4.68 (3.74-5.95) | <0.001∗ |
| Lymphocyte (109/l) | 1.17 (0.9-1.5) | 1.59 ± 0.51 | 1.19 ± 0.35 | 1.15 ± 0.34 | 0.93 ± 0.32 | <0.001∗ |
| Platelet (109/l) | 171.5 (134-216) | 159.66 ± 53.75 | 211.54 ± 61.67 | 134.27 ± 47.39 | 201.16 ± 66.98 | <0.001∗ |
| Hb (g/l) | 112 (102-121) | 116 (108-123) | 108.68 ± 15.37 | 110.49 ± 12.97 | 110 (98-116.5) | <0.001∗ |
| ALB (g/l) | 40.55 (38-42.6) | 41.4 (38.5-43.2) | 40.2 (37.83-41.7) | 40.1 (37.2-42.55) | 40.2 (38.05-42.55) | 0.138 |
| Cholesterol (mmol/l) | 4.01 ± 0.95 | 4.03 ± 0.98 | 4.16 ± 0.9 | 3.89 ± 0.94 | 3.83 (3.3-4.6) | 0.417 |
| TG (mmol/l) | 1.45 (1.02-2.18) | 1.64 (1.11-2.25) | 1.37 (1.02-1.93) | 1.53 (1.09-2.19) | 1.32 (0.96-2.25) | 0.109 |
| Ca (mmol/l) | 2.28 ± 0.22 | 2.27 ± 0.24 | 2.31 ± 0.18 | 2.22 ± 0.24 | 2.29 ± 0.2 | 0.433 |
| P (mmol/l) | 1.99 (1.61-2.3) | 2.01 ± 0.57 | 1.89 ± 0.39 | 1.91 ± 0.62 | 2.05 ± 0.56 | 0.37 |
| CRP (mmol/l) | 3.55 (1.8-10.28) | 2.99 (1.77-9.78) | 3.13 (1.37-8.16) | 4.87 (2–11.53) | 3.78 (1.85-11.74) | 0.445 |
| NLR | 3.42 (2.54-4.78) | 2.39 ± 0.59 | 2.77 ± 0.48 | 4.03 (3.65-5.01) | 5.09 (4.07-6.62) | <0.001∗ |
| PLR | 142.38 (110.48-194.55) | 102.94 ± 26 | 167.03 (154.16-190.61) | 120.66 (105.81-133.83) | 206.01 (168.67-259.43) | <0.001∗ |
∗Significant difference according to four groups, p < 0.05. Values are means ± SD or median (25th-75th percentile), unless specified otherwise. NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; ALB: albumin; Hb: hemoglobin; TG: triglyceride; Ca: calcium; P: phosphorus; CRP: C-reactive protein.